+
Rossari Biotech plans to acquire Tristar Intermediates for Rs 120 cr
Products

Rossari Biotech plans to acquire Tristar Intermediates for Rs 120 cr

Rossari Biotech Limited, a specialty chemicals manufacturer, told the media that it has agreed to acquire Tristar Intermediates Pvt Ltd for Rs 120 crore in multiple tranches.

Rossari Biotech said that the acquisition will occur in multiple tranches.

It will acquire a 76% equity stake of Tristar by September this year, as part of the first tranche, and the remaining will be acquired by the financial ending March 31, 2025.

As part of its inorganic growth plan, the acquisition is in line with Rossari Biotech's strategy to set its place in specialty chemicals manufacturing.

Tristar allows synergies in manufacturing and marketing that can be highly valued accretive in the long run.

Tristar is involved in the manufacture and trade of organic and inorganic chemicals and was incorporated on September 1, 1997.

It has three manufacturing plants with a capability of 15,000 million tonnes per annum (MTPA).

It had registered a turnover of Rs 110.5 crore in the last financial year 2020-21 against Rs 95.2 crore in the prior fiscal year.

Rossari Biotech announced last month that it will buy Unitop Chemicals Private for Rs 421 crore in an all-cash deal.

Marking its first initial public offering (IPO) since India went into a lockdown in late March to manage the pandemic, Rossari went public in July last year.

Before that, the company had raised Rs 100 crore by allocating shares to eight institutional investors in a pre-initial public offering (IPO) round.

Image Source

Rossari Biotech Limited, a specialty chemicals manufacturer, told the media that it has agreed to acquire Tristar Intermediates Pvt Ltd for Rs 120 crore in multiple tranches. Rossari Biotech said that the acquisition will occur in multiple tranches. It will acquire a 76% equity stake of Tristar by September this year, as part of the first tranche, and the remaining will be acquired by the financial ending March 31, 2025. As part of its inorganic growth plan, the acquisition is in line with Rossari Biotech's strategy to set its place in specialty chemicals manufacturing. Tristar allows synergies in manufacturing and marketing that can be highly valued accretive in the long run. Tristar is involved in the manufacture and trade of organic and inorganic chemicals and was incorporated on September 1, 1997. It has three manufacturing plants with a capability of 15,000 million tonnes per annum (MTPA). It had registered a turnover of Rs 110.5 crore in the last financial year 2020-21 against Rs 95.2 crore in the prior fiscal year. Rossari Biotech announced last month that it will buy Unitop Chemicals Private for Rs 421 crore in an all-cash deal. Marking its first initial public offering (IPO) since India went into a lockdown in late March to manage the pandemic, Rossari went public in July last year. Before that, the company had raised Rs 100 crore by allocating shares to eight institutional investors in a pre-initial public offering (IPO) round. Image Source

Next Story
Equipment

BorgWarner to Supply VTG Turbochargers for HEVs

BorgWarner Inc. has secured a contract with a major European original equipment manufacturer (OEM) to supply its variable turbine geometry (VTG) turbocharger for a hybrid electric vehicle (HEV) platform. The agreement positions the company within the OEM’s global supply chain and will support one of its first HEV offerings in North America. Start of production is scheduled for 2028. The VTG turbocharger is engineered to deliver precise engine control across a wide speed range, enhancing performance, fuel efficiency and emissions management. Electrically actuated adjustable vanes regulate pr..

Next Story
Infrastructure Energy

Jyoti Structures expands manufacturing capacity in Nashik

The announcement Jyoti Structures (JSL) reported steady operational performance in 2025, supported by stable project execution across its power transmission portfolio. The company commissioned galvanisation operations at its second Nashik manufacturing unit, adding 33,000 MT of annual capacity. This increased aggregate tower manufacturing capability at Nashik to approximately 69,000 MT per annum, aimed at improving fabrication accuracy, scheduling control and delivery predictability. JSL also expanded its workforce to over 750 employees, onboarding more than 70 engineers during the year. C..

Next Story
Infrastructure Energy

TSPL Mega Health Camp Reaches 338 Residents in Mansa

Talwandi Sabo Power (TSPL), Punjab’s largest and North India’s largest private thermal power plant, organised a Mega Health Camp at Village Raipur, Mansa, under its flagship healthcare initiative Project SEHAT. The camp benefitted 338 community members through free consultations and diagnostic services.A team comprising a General Physician, Gynaecologist, Dermatologist and Dentist provided medical advice and treatment. Beneficiaries received free diagnostic tests including BP, HB, blood sugar, malaria, dengue and blood group tests, along with free medicines.The camp was inaugurated by Vill..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Open In App